E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/20/2016 in the Prospect News PIPE Daily.

Aytu Bioscience completes $200,000 private placement of common stock

Company sells 307,692 of its shares at $0.65 per share to CEO and COO

By Devika Patel

Knoxville, Tenn., Jan. 20 – Aytu Bioscience Inc. settled a $200,000 private placement of stock on Jan. 20, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 307,692 common shares at $0.65 per share, a 27.78% discount to the Jan. 19 closing share price of $0.90.

Chief executive officer Joshua R. Disbrow and chief operating officer Jarrett T. Disbrow each purchased 153,846 shares for $100,000 apiece.

The health care company is based in Englewood, Colo.

Issuer:Aytu Bioscience Inc.
Issue:Common stock
Amount:$200,000
Shares:307,692
Price:$0.65
Warrants:No
Investors:Joshua R. Disbrow (for $100,000), Jarrett T. Disbrow (for $100,000)
Settlement date:Jan. 20
Stock symbol:OTCBB: AYTU
Stock price:$0.90 at close Jan. 19
Market capitalization:$11.69 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.